Evidence map›Paper›PMID 33511305›Full record

ArticleNanoImpact2020

Pilot deep RNA sequencing of worker blood samples from Singapore printing industry for occupational risk assessment.

Nancy Lan Guo, Dhimiter Bello, Qing Ye, Rebecca Tagett, Lucia Chanetsa, Dilpreet Singh, Tuang Yeow Poh, Magdiel Inggrid Setyawati, Sanjay H Chotirmall, Kee Woei Ng and 1 more

Open access · hybridAbstract read
In one paragraph

Article in NanoImpact, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Nancy Lan GuoWest Virginia University Cancer Institute/School of Public Health, West Virginia University, Morgantown, WV 26506.
Dhimiter BelloDepartment of Biomedical and Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, MA 01854.
Qing YeLane Department of Computer Science and Electrical Engineering, Statler College of Engineering and Mineral Resources, West Virginia University, Morgantown, WV 26506.
Rebecca TagettBRCF Bioinformatics Core, University of Michigan Medical School, Ann Arbor, MI 48109.
Lucia ChanetsaDepartment of Biomedical and Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, MA 01854.
Dilpreet SinghCenter for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
Tuang Yeow PohLee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
Magdiel Inggrid SetyawatiSchool of Materials Science and Engineering, Nanyang Technological University, Singapore 639798, Singapore.
Sanjay H ChotirmallLee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
Kee Woei NgCenter for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
Philip DemokritouCenter for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
Nanyang Technological University · SGHarvard University · USWest Virginia University · USUniversity of Massachusetts Lowell · USUniversity of Michigan–Ann Arbor · US

Funding

Systematic assessment of multi-walled carbon nanotubes in pulmonary diseaseR01ES021764 · NIEHS · WEST VIRGINIA UNIVERSITY · PI GUO, NANCY LAN · 2012 to 2016
$1.7M
NIEHS NIH HHS R01 ES021764
6 · The paper itself

Abstract

Several engineered nanomaterials (ENMs) are used in toner-based printing equipment (TPE) including laser printers and photocopiers to improve toner performance. High concentration of airborne nanoparticles due to TPE emissions has been documented in copy centers and chamber studies. Recent animal inhalation studies by our group suggested exposure to laser printer-emitted nanoparticles (PEPs) increased cardiovascular risk by impairing ventricular performance and inducing hypertension and arrhythmia, consistent with global transcriptomic and metabolomic profiling results. There has been no genome-wide transcriptomic analysis of workers exposed to TPE emissions to systematically assess the occupational exposure health risks. In this pilot study, deep RNA sequencing of blood samples of workers in two printing companies in Singapore was performed. The genome-scale analysis of the blood samples from TPE exposed workers revealed perturbed transcriptional activities related to inflammatory and immune responses, metabolism, cardiovascular impairment, neurological diseases, oxidative stress, physical morphogenesis/deformation, and cancer, when compared with the control peers (office workers). Many of these disease risks associated with particle inhalation exposures in such work environments were consistent with the observation from the PEPs rat inhalation studies. In particular, the cell adhesion molecules (CAMs) was a top significantly perturbed pathway in blood samples from exposed workers compared with the office workers in both companies. The protein expression of sICAM was verified in plasma of exposed workers, showing a positive correlation with daily average nanoparticle concentration in indoor air measured in these two companies. Larger scale genomic and molecular epidemiology studies in copier operators are warranted in order to assess potential risks from such particulate matter exposures.

Indexed as

disease risksengineered nanomaterials (ENMs)inhalation exposureprinter-emitted nanoparticles (PEP)RNA sequencingToner-based printing equipment (TPE)toxicity

Identifiers

PMID33511305
PMCPMC7840153
OpenAlexW3049461182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.